AJP - Endocrinology and Metabolism, Vol 266, Issue 3 E384-E395, Copyright © 1994 by American Physiological Society

ARTICLES

Isotopomer spectral analysis of cholesterol synthesis: applications in human hepatoma cells

J. K. Kelleher, A. T. Kharroubi, T. A. Aldaghlas, I. B. Shambat, K. A. Kennedy, A. L. Holleran and T. M. Masterson
Department of Physiology, George Washington University Medical Center, Washington, DC 20037.

Cholesterol synthesis from 13C-labeled precursors produces a discrete spectrum of mass isotopomers detectable using gas chromatography-mass spectrometry. The isotopomer spectral analysis (ISA) method matches the observed spectrum of cholesterol isotopomers with a mathematical model to obtain the best fit of model spectrum to data spectrum. The model was based on multinomial probability expressions that simulate cholesterol synthesis as a condensation of mevalonate fragments. As many as four unknown parameters, representing fluxes between compartments, were included in the model. Models were developed to assess cholesterol synthesis from 13C-enriched precursors including mevalonate, acetate, acetoacetate or octanoate. Models were tested in the human hepatoma cell line, Hep G2, which readily incorporated the 13C substrates into cholesterol. The ISA approach was used to estimate the fractional amount of the cholesterol precursors derived from the 13C substrate and the fraction of total cellular cholesterol synthesized in the presence of the 13C substrate. The study demonstrated the feasibility of the ISA approach for a condensation biosynthesis that is not a simple polymerization and for models with more than two unknown parameters.

This article has been cited by other articles:

				B. Lindenthal, T. A. Aldaghlas, A. L. Holleran, T. Sudhop, H. K. Berthold, K. von Bergmann, and J. K. Kelleher Isotopomer spectral analysis of intermediates of cholesterol synthesis in human subjects and hepatic cells Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1222 - E1230. [Abstract] [Full Text] [PDF]

				B. LINDENTHAL, A. L. HOLLERAN, T. A. ALDAGHLAS, B. RUAN, G. J. SCHROEPFER Jr, W. K. WILSON, and J. K. KELLEHER Progestins block cholesterol synthesis to produce meiosis-activating sterols FASEB J, March 1, 2001; 15(3): 775 - 784. [Abstract] [Full Text] [PDF]

				M. K. Hellerstein and R. A. Neese Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1146 - E1170. [Abstract] [Full Text] [PDF]

				S. F. Previs, P. T. Hallowell, K. D. Neimanis, F. David, and H. Brunengraber Limitations of the Mass Isotopomer Distribution Analysis of Glucose to Study Gluconeogenesis. HETEROGENEITY OF GLUCOSE LABELING IN INCUBATED HEPATOCYTES J. Biol. Chem., July 3, 1998; 273(27): 16853 - 16859. [Abstract] [Full Text] [PDF]

				P. J. H. Jones, L. M. Ausman, D. H. Croll, J. Y. Feng, E. A. Schaefer, and A. H. Lichtenstein Validation of deuterium incorporation against sterol balance for measurement of human cholesterol biosynthesis J. Lipid Res., May 1, 1998; 39(5): 1111 - 1117. [Abstract] [Full Text]

				B. Comte, G. Vincent, B. Bouchard, and C. D. Rosiers Probing the Origin of Acetyl-CoA and Oxaloacetate Entering the Citric Acid Cycle from the 13C Labeling of Citrate Released by Perfused Rat Hearts J. Biol. Chem., October 17, 1997; 272(42): 26117 - 26124. [Abstract] [Full Text] [PDF]